Clinical data, regulatory milestones, AI-assisted discovery platforms, and expanding development pipelines are creating a steady stream of catalysts that investors will be watching closely during the ...
Biohaven Ltd. BHVN shares fell Monday after Bank of America Securities (BofA) downgraded the biotechnology company, citing an ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. By 2020, U.S. healthcare data had reached 2,314 exabytes—15 times more than in 2013—thanks ...
Ocugen’s model fair value holds at US$11.43 per share, with no change to the underlying price target despite fresh clinical ...
Early data suggest KLN-1010, now acquired by Eli Lilly, could be more tolerable but less efficacious that AstraZeneca’s ESOT-01.
WASHINGTON and COLUMBUS, Ohio, April 28, 2026 /PRNewswire/ -- Today, Paradigm Health announced the launch of a landmark research collaboration with the U.S. Food & Drug Administration (FDA) focused on ...
In the late 1800s, the U.S. railroad system didn’t just revolutionize transportation—it catalyzed entirely new industries. Refrigerated railcars enabled a national meatpacking economy. Standard time ...
Although the potential transformative effect of electronic health record (EHR) data on clinical research in adult patient populations has been very extensively discussed, the effect on pediatric ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today shared the first clinical results from two of its siRNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results